Justine Cohen, DO

Justine V. Cohen is a medical oncologist at Dana-Farber Cancer Institute. She is a clinical and translational investigator specializing in the treatment of patients with melanoma with specific research interests in the adaptation of promising preclinical findings into new clinical trials, the development of novel combinations of immune modulating agents for the treatment of malignant melanoma, broadening treatment options for patients with brain metastases, and the study of immune-related toxicities. She completed a mid-career fellowship in Hospice and Palliative Medicine and she serves as the liaison for melanoma in the Center for Cancer Therapeutic Innovation (Early Drug Development Program). Dr. Cohen is also the lead melanoma oncologist for the Cancer Care Equity Program at Dana-Farber Cancer Center as well as for the Dana-Farber Collaborative Network. Dr. Cohen hopes to find ways of minimizing toxicity and maximizing quality of life in patients undergoing treatment for melanoma. H